Miwa H et al. |
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383502
|
Ducóns JA et al. |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383507
|
Calvet X et al. |
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383508
|
Sieg A et al. |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383519
|
Grimley CE et al. |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383520
|
Houben MH et al. |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383522
|
Tomiyama Y et al. |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. |
1999 |
Kekkaku |
pmid:10386036
|
Stewart AK et al. |
Lack of response to short-term use of clarithromycin (BIAXIN) in multiple myeloma. |
1999 |
Blood |
pmid:10391696
|
Raderer M et al. |
Successful symptomatic management of a patient with Ménétrier's disease with long-term antibiotic treatment. |
1999 Jul-Aug |
Digestion |
pmid:10394031
|
Tsukamoto T et al. |
Biofilm in complicated urinary tract infection. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10394976
|
Hafner R et al. |
Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection. |
1999 |
J. Infect. Dis. |
pmid:10395860
|
Inoue M et al. |
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]. |
1999 |
Jpn J Antibiot |
pmid:10396687
|
Lasko B et al. |
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. |
1998 |
J. Int. Med. Res. |
pmid:10399110
|
Horgan SE et al. |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. |
1999 |
J. Med. Microbiol. |
pmid:10403423
|
Mera R et al. |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. |
1999 |
J. Clin. Gastroenterol. |
pmid:10405232
|
Katsura Y et al. |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles. |
1999 |
J. Med. Chem. |
pmid:10425101
|
Grimm KJ |
Treatment of Helicobacter pylori infection in functional dyspepsia. |
1999 |
J Fam Pract |
pmid:10428242
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Kyzekova J and Mour J |
The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. |
1999 May-Jun |
Hepatogastroenterology |
pmid:10430396
|